Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
Jacques Maas, Head Center for Reproductive Medicine at Maastricht UMC+, shared a post on LinkedIn:
“When two research schools of Maastricht University Faculty of Health, Medicine and Life Sciences and Maastricht UMC+: MERLN Institute for Technology-Inspired Regenerative Medicine and GROW – Research Institute for Oncology and Reproduction find each other and utilize long-standing, fruitful collaborations in the Netherlands in the field of endometriosis and adenomyosis, the impossible apparently becomes possible.
Roman Truckenmüller, Paul Wieringa, Niloofar Tahmasebi, and Erik Vrij have been awarded the prestigious NWO (Dutch Research Council) Perspective Grant for the project ‘FEMCHIP – Tackling endometriosis and adenomyosis through improved clinical diagnostics and human in vitro models to unlock understanding and therapy development’.
FEMCHIP aims to transform the diagnosis and treatment of endometriosis and adenomyosis by developing innovative imaging tools, creating advanced 3D disease models, and identifying new therapies to reduce pain and improve fertility.
The FEMCHIP consortium is a collaboration between Maastricht University, MUMC+, UMC Utrecht, Amsterdam UMC, and Radboud University. To address the urgent need for better diagnostics and treatments, FEMCHIP collaborates closely with Dutch and international industry partners, patient organizations, and innovation hubs to accelerate solutions for these underserved diseases.
Programme lead: prof. dr. Roman K. Truckenmüller
Co-applicants: dr. ir. P.A.W. Wieringa, dr. ir. E.J. Vrij, dr. Z.N. Tahmasebi Birgani, Jacques Maas, Salwan Al-Nasiry, Andrea Romano, Velja Mijatovic, Judith Huirne, Arjan W. Griffioen, Lynda Juffermans, Bernadette de Bakker, Lennie Van Hanegem, Willem Verpoest, Gaby Steba, Klaas Mulder, prof. dr. M. Vermeulen
Consortium: Endometriose Stichting, Genomics, 300MICRONS GmbH, chiron, CimCure B.V., Fluidnatek and Spinbox by Bioinicia, ibidi GmbH, Little Miracles Foundation, Merck Group, Metatissue, Olink, Optics11 Life, Proefdiervrij, ReGEN Biomedical, Samsung Healthcare, STEMCELL Technologies, Theramex, TNO, and Topigs Norsvin”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 16, 2026, 13:30Simon Meagher and Rabih Chaoui Discuss Fetal Heart Scanning in the Latest ISUOG Podcast – ISUOG
-
Mar 16, 2026, 12:58Exploring the Link Between Adenomyosis and Proliferative Endometrial Disorders – Fertility and Sterility
-
Mar 16, 2026, 12:55Nicola Pozzi: A New Mechanism to Reduce Thrombus Formation Without Increasing Bleeding Risk
-
Mar 16, 2026, 12:44Endometriosis Awareness Month Virtual Issue! – ISUOG
-
Mar 16, 2026, 12:30Jeanne Conry: When the Government Intervenes, Women Die
-
Mar 16, 2026, 12:23Magdalena Simonis Highlights the Need to Change the Rhetoric on Endometriosis
-
Mar 16, 2026, 12:00Julia Chain Highlights Fertility Preservation as Part of Women’s Health Campaign – HFEA
-
Mar 15, 2026, 15:26Watching Life Begin: Scientists Track Embryo Implantation in Real Time! – Science Magazine
-
Mar 15, 2026, 15:03Reem Abu-Rustum Spotlights Fetal Situs in New ISUOG Quiz – ISUOG